Members of Mallinckrodt PLC’s board of directors are facing a putative class action alleging they defrauded investors during the pharmaceutical company’s bankruptcy proceedings.
Plaintiff Darrel Edelman, represented by Haviland Hughes, filed the suit on behalf of himself and a proposed class of “potentially thousands” of other Mallinckrodt investors who opted out of individual releases offered during Mallinckrodt’s Chapter 11 bankruptcy.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]